top of page
In answer to Coronavirus pandemic,
ISOP ISRAEL is currently working to switch some of its workshops to webinars 
We will start in Q4 -2020

ISOP ISRAEL is proud to offer an inspiring program of 4 to 6 hours workshops, which will be held in Hebrew, by top-notch experts who will share their experience with you.

Based on the same concept that our symposium, the seminars will be multidisciplinary, and solution-oriented.


To share proven methods and tools that you could apply in your environment.


Sheba Medical Center

Machon Autoimmunity


New Strategies for a Safer Use of Anticoagulants

Chair :


Ariel University

Adelson Faculty of Medicine

download (3).jpg

Motherisk International Inaugural Workshop Treating the Mother,

Protecting the Unborn and the Newborn

Chair :


Head, Pharmacology

Head of Institute of Clinical Pharmacology and Toxicology. Sheba Medical Centre

1-Tools and methods

- IHI Trigger tool to detect Adverse Drug Reactions in electronic Medical Records

-ISMPâMedication Safety Self-assessment for antithrombotic therapy

- Risk Communication to patient : BeMedwise

Adelson Faculty of Medicine, Ariel University

and Motherisk Israel Program, Shamir Hospital

Speakers :

to be confirmed

Prof Asher Ornoy

Prof Ilan Matok

Rana Cohen MSc

Prof Mati Berkovitch,

Dr Gali Pariente

Dr Shirin Namouz

Prof. Orna Citrin

Prof Didi Bentur

Mgr Maya Berlin

Chagit Klieger

Dr Yael Grin

2 -Experience sharing:  Initiatives that work

- Sheba Medical Center

- Maayanei HaYeshua  Medical Center

September 2020

Hadassah Medical Center


December 2020 

Pharma Company (tbc)

Tel Aviv region


Deprescribing is an urgency! 

Highlight on elderly patients

Chair :

Internist and Clinical Pharmacologist. Head of the Department of Medicine at the Hadassah University Hospital, Mt Scopus Campus, Jerusalem.

  • What is the extent of the issue?

  • The clever use of drugs in elderly people

  • Review of the tools for assessing polypharmacy: BEERS, STOP & START, Medication Appropriateness Index …

  • Who must be involved in the multidisciplinary approach? All stakeholders :  any prescriber, the pharmacists and clinical pharmacists, the pharmacologists, the patients, the Ministry of Health, the Kupot Holim , the Industry and the Academy.

  • How to be involved ? : review of current initiatives

  • Review of the current tools, including the potential or current Artificial Intelligence solutions.

What the guidelines are telling us? do we need new guidelines?

November 2020 Sheba Medical Center

Machon Autoimmunity

images (6).jpg

Bio-pharmaceuticals, Biosimilars:
Israel and International Standards

Chair :

Head of Institute of Clinical Pharmacology and Toxicology. Sheba Medical Centre

Program under construction

  ISOP ISRAEL is considering to organise its
2nd  full-day symposium on this topic.


  • Clinician physicians, hospital &community, especially geriatrics, obstetricians, gynecologists, cardiologists, general practitioners, clinical pharmacologists

  • Pharmacists, Clinical Pharmacists, hospital &community

  • Risk managers, patient safety staff, quality of care staff

  • Nurses

  • Kupot Holim

  • Industry: Pharmacovigilance, marketing, regulatory affairs, medical affairs

  • Academy: Public Health, pharmacology, school of Pharmacy, school of Medicine, nurses ‘school, geriatrics, family physicians

  • Ministry of Health: Pharmacovigilance, risk management, quality of care, patient safety, geriatrics 

bottom of page